Our Mission
Strokes and severe traumatic brain injuries are the number one cause of preventable disability.
Our aim is to aid medical personnel and support them in their effort to detect, monitor, and manage brain conditions in real-time.
We strive to improve patient outcomes and increase
Our Mission
Strokes and severe traumatic brain injuries are the number one cause of preventable disability.
Our aim is to aid medical personnel and support them in their effort to detect, monitor, and manage brain conditions in real-time.
We strive to improve patient outcomes and increase
Our Vision
We’re building a future where Sense technology can complement subjective methods of assessment and monitor physical brain conditions in real-time.
We’re making real-time brain monitoring a reality in the field, as well as in the hospital.
Our Vision
We’re building a future where Sense technology can complement subjective methods of assessment and monitor physical brain conditions in real-time.
We’re making real-time brain monitoring a reality in the field, as well as in the hospital.
Team
Geoff Klass
CEO
Respected senior executive in business and community leadership. With over 30 years of building commercial organizations, from startups to global enterprises; Geoff has a deep healthcare and neuro innovation background.
Daniel Kincaid
COO
Serial entrepreneur, and seed-stage investor with 25 years of experience as a healthcare executive. Dan provides strategic planning, bringing to the table expert mentoring and market validation.
Opeolu Adeoye
MD, CMO
George Shaw
MD, PhD, CTO
Responsible for the technical and scientific development of Sense device, Dr. Shaw shares a unique vision of improving care for emergency medicine patients. He provides the clinical structure and the highest standards for experiment methodology and data analysis.
Joe Korfhagen
PhD, Director, R&D
As Director of R&D, Joe focuses on developing the Sense device and enhancing the technology driving the product. Joe’s career goal is to create medical devices that will improve the standard of care for patients suffering from neurological disease.
Matt Flaherty
MD, CCO
Dr. Flaherty practices general neurology with an emphasis on stroke care. He is a prolific author in the area of cerebrovascular disease and was awarded the Michael S. Pessin Stroke Leadership Prize by the American Academy of Neurology in 2009.
Paul Gaitan
CFO
Paul Gaitan is a seasoned CFO with experience most recently with Haag-Streit USA and Workhorse Group. Paul earned his BS degree in business from the University of Southern California and his MBA from Stanford University with a concentration in production control systems.
Sara Keegan
Director of Clinical Operations
As Director of Clinical Operations, Sara oversees pivotal trials across multiple sites for the devices Sense is developing. Sara brings 18 years of clinical research experience managing multi-center, national trials. She holds BAs in Biology and Psychology and an MEd in Health Promotion and Education.
Board of Directors
Daniel Geeding
Board Chair, Director
Daniel Geeding is a professor emeritus of management and former director of the Center for International Business at Xavier University. Served as dean of Xavier’s Williams College of Business and as director of the college’s Center for Management and Professional Development and the Executive MBA Program.
Jack Kraeutler
Director
Jack Kraeutler is former CEO of Meridian Bioscience, Inc., whose distinguished career includes more than 45 years of experience in the biomedical industry. He has held numerous board positions, and was also an appointed member of the Ohio Third Frontier Commission and former vice-chair of BIOSTART.
Sally Evans Kay
Director
Sally Evans Kay is a corporate innovator and mentor whose career includes 36 years with the Dow Chemical Company and GlaxoSmithKline Consumer Healthcare, where she held positions in R&D, finance, sales, marketing and new product development and innovation.
Carol Warner
Director
Carol Warner is a finance professional with significant experience in the Dayton region start-up community, including investments of the Dayton Development Coalition sponsored venture funds. Her career included over 20 years with AT&T and its subsidiaries.
Geoff Klass
CEO
Daniel Kincaid
COO
Opeolu Adeoye
MD, CMO
Scientific Advisory Board
Lori Shutter
Director of Neurocritical Care & Vice Chair Of Education, Critical Care Medicine
James Grotta, MD
Neurologist, Vascular Neurologist, Director of Stroke Research, Director Mobile Stroke Unit, Memorial Hermann Hospital
John Tew
Professor of Neurosurgery at the University of Cincinnati and UC Health
Harry van Loveren
David W. Cahill Professor and Chair of Neurosurgery at the University of South Florida
David Wright, MD
Professor at Emory University School of Medicine
Investment to Date
Queen City Angels
(Cincinnati)
Accelerant Fund
(Dayton, OH)
Strategic NeuroPhysician Investors
National Science Foundation
Frontier Angels
Anges Quebec
Contact Us
Our team works diligently to make our innovative brain scanner a reality for patients.
We are driven by our mission and are committed to impacting people’s lives and enhancing neurological health globally.
Copyright Sense Neuro 2021 All Rights Reserved. Designed by Node